TherapyX Inc. – Trademark Portfolio

Entity Type: 03

TherapyX Inc. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 13 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. The owner is based in Buffalo, NY.

3435 Main Street

Buffalo, NY 14214

14 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

FAPXIL
FAPXIL
Abandoned 2020
PCX12
PCX12
Abandoned 2020
ATRAXIM
ATRAXIM
Abandoned 2020
GNEX12
GNEX12
Abandoned 2020
NGOXIM
NGOXIM
Abandoned 2020
NGOXIM
NGOXIM
Abandoned 2018
EXSTAM
EXSTAM
Abandoned 2018
ATRAXIM
ATRAXIM
Abandoned 2018
NGOXIL
NGOXIL
Abandoned 2017
GNEX12
GNEX12
Abandoned 2017
GVAX12
GVAX12
Abandoned 2017
TREXTAM
TREXTAM
Abandoned 2017

Trademark Classifications

TherapyX Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (13 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does TherapyX Inc. have?

TherapyX Inc. has 14 U.S. trademarks filed with the USPTO.

What trademark classes does TherapyX Inc. file in?

TherapyX Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is TherapyX Inc.'s trademark registration success rate?

TherapyX Inc. has a 0% trademark registration rate, with 0 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.